483
Pharmathen International S.A.FDA 483 - Pharmathen International S.A. - March 09, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Pharmathen International S.A., a drug manufacturer in Rodopi, Greece, revealed significant deficiencies in aseptic processing, laboratory controls, and quality control unit procedures. The firm failed to ensure proper disinfectant contact times, lacked adequate testing for visible particulates in injectable products, and did not perform periodic audit trail reviews of electronic data.
- Office
- Office of Partnerships
- Person
Open in Dashboard
ID · 525440ef-3876-4305-bbb1-43cddf39afce